BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Protiva Biotherapeutics INC

Protiva is a development stage biotechnology company, focused on pharmaceutical products to fight serious human disease. Protiva's proprietary SNALP technology enables the development of novel nucleic acid-based drugs, such as those that utilize siRNA. Protiva was founded in September of 2000 based on technology developed at The University of British Columbia.Protiva's headquarters is in Seattle, WA and its R&D facility is in Vancouver, B.C. Protiva's incorporation in Delaware is pending


Contact Details:
100-3480 Gilmore Way
Burnaby
British Columbia
V5G 4W7
Canada
Tel:604 630-5061
Fax:604.630-5103
Email:information@protivabio.com
WWW:

www.protivabio.com/




Loading...

Recent Publications by Protiva Biotherapeutics INC:

Misinterpreting the therapeutic effects of siRNA caused by immune stimulation.
Activation of innate immunity has direct effects in modulating viral...
21st August, 2008
Protiva Biotherapeutics Inc., Burnaby, British Columbia, Canada; Hum Gene Ther. 2008 Aug 19.
DOI Direct Link
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids.
An analogous series of cationic lipids...
15th December, 2005
Protiva Biotherapeutics Inc., 100-3480 Gilmore Way, Burnaby, B.C., Canada J Control Release. 2005 Oct 3;107(2):276-87.
DOI Direct Link
A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.
PURPOSE: A fully scalable and extrusion-free method was developed to...
10th August, 2005
Protiva Biotherapeutics Inc., Burnaby, British Columbia, Canada V5G 4Y1. Pharm Res. 2005 Mar;22(3):362-72.
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression.
Stabilized plasmid lipid particles (SPLP) consist of a single copy of DNA...
22nd July, 2005
Protiva Biotherapeutics Inc., 100-3480 Gilmore Way, Burnaby, BC, Canada Biochim Biophys Acta. 2005 May 20;1669(2):155-63. Epub 2005 Feb 24.
DOI Direct Link

BioNews Results for Protiva Biotherapeutics INC:

Tekmira Pharmaceuticals Expands Executive Management Team
Healthcare Sales & Marketing Network:  Oct 2 2008 10:37AM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team
Nanotechnology News:  Sep 30 2008 1:59AM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team
BC Technology:  Sep 30 2008 1:06AM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team
TradingMarkets:  Sep 29 2008 3:07PM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team
TMC Net:  Sep 29 2008 4:05PM Matching: protiva biotherapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Protiva Biotherapeutics INC news.

Protiva Biotherapeutics INC Patents:

US Patent No.Title
6841537 Combination therapy using nucleic acids and conventional drugs
6410328 Sensitizing cells to compounds using lipid-mediated gene and compound delivery

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 187 times since April 2007, the link to the organisation's website has been followed 37 times

Recent Search Terms used to find this page: Protiva Biotherapeutics Inc | information protivabio com | protiva The University of British Columbia | protiva incorporation | protiva incorporation | protiva incorporation | TEKMIRA AND SPLP TECHNOLOGY | tekmira and SPLP technology | Protiva Vancouver 2000 | .

Search for more companies in Burnaby

Search for more companies in British Columbia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Protiva Biotherapeutics INC
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.